Company / Interest Expense per Share
Vertex Pharmaceuticals Interest Expense per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.22
FY2020
5-year range
-
FY2017-FY2020
Trend
-2.1%
vs FY2019
Sector context
#20 of 43
Health Care
What the data says
At $0.22, Vertex Pharmaceuticals's interest expense per share ranks #24 of 43 in the Health Care sector. Improved from $0.29 to $0.22 over the past 2 years.
Based on SEC 10-K filings.
0.22 in FY2020 with a 3-year CAGR of -7.0%.
Improved from $0.29 to $0.22 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -7.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#24 of 43 in Health CareTop 53% of 43This company $0.22 Sector average $18.61
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2020, interest expense per share decreased 2.1% year-over-year.
- Ranks #20 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.22 | -2.1% |
| FY2019 | $0.23 | -19.9% |
| FY2018 | $0.29 | +2.5% |
| FY2017 | $0.28 | - |
| FY2016 | - | - |
As of FY2020 · SEC 10-K · Updated Mar 17, 2026